Patient Medication Information: uses, side effects, how to take - Idacio (Fresenius Kabi Canada, PM 00076425)
Serious Warnings and Precautions
Before starting, during and after treatment with Idacio, you/your child should be checked for active or inactive tuberculosis infection with a tuberculin skin test. Any medicine can have side effects. Like all medicines that affect your/your child’s immune system, Idacio can cause serious side effects. The possible serious side effects include:
|
|---|
|
|---|
What is Idacio used for?
Idacio is a medicine that is used in:
- adults with rheumatoid arthritis, which is an inflammatory disease of the joints.
- adults with psoriatic arthritis, which is an inflammatory disease of the joints and skin.
- adults with ankylosing spondylitis, which is a form of arthritis.
- adults with Crohn’s disease, which is an inflammatory disease of the digestive tract.
- patients 2 years of age and older who have polyarticular juvenile idiopathic arthritis, which is an inflammatory disease affecting one or more joints, with diagnosis typically occurring in children under the age of 16 years.
- children 13 to 17 years weighing ≥40 kg who have severe Crohn’s disease or who have Crohn’s disease which has not responded to other usual treatments. Crohn’s disease is an inflammatory disease of the digestive tract.
- adults with ulcerative colitis, which is an inflammatory disease of the bowel (colon).
- adults or adolescents (12 to 17 years of age, weighing ≥30 kg) with moderate to severe hidradenitis suppurativa (HS) who have not responded to antibiotics. HS is a painful, progressive, chronic inflammatory skin disease that causes nodules, abscesses, sinus tracts and fistulas under the breasts, underarms, buttocks and groin.
- adults with psoriasis, which is an inflammatory disease of the skin. The doctor prescribed Idacio to reduce the signs and symptoms of your plaque psoriasis.
- adults with uveitis, which is an inflammatory disease of the eye.
- children with chronic non-infectious uveitis from 2 years of age with inflammation affecting the front of the eye.
Patients with rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, hidradenitis suppurativa, psoriasis, or uveitis may be given other medicines for their disease before they are given Idacio. If you have ulcerative colitis or you/your child have Crohn’s disease, you/your child will first be given other medicines. If you/your child do not respond well enough to these medicines, you/your child will be given Idacio to reduce the signs and symptoms of your/your child’s disease.
How does Idacio work?
Idacio is a fully human monoclonal antibody produced by cultured cells. Monoclonal antibodies are proteins that recognize and bind to other unique proteins. Idacio binds to a specific protein called TNF-alpha (also known as tumor necrosis factor). People with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, hidradenitis suppurativa or psoriasis have too much of TNF-alpha in their bodies. The extra TNF-alpha in your/your child’s body can attack normal healthy body tissues and cause inflammation, especially in the tissues of your /your child’s bones, cartilage, joints, digestive tract and skin. By binding to TNF-alpha, Idacio decreases the inflammation process of these diseases.
Idacio helps reduce the signs and symptoms of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and psoriatic arthritis (such as pain and swollen joints), may help improve your/your child’s ability to perform daily activities (such as getting dressed, walking and climbing stairs), and may help prevent further damage to your/your child’s bones and joints. In addition, Idacio helps reduce the signs and symptoms of ankylosing spondylitis (back pain and morning stiffness), and adult and pediatric Crohn’s disease or ulcerative colitis (abdominal pain and diarrhea). Idacio may also help normalize childhood growth and pubertal development and improve the quality of life in children who have Crohn’s disease (such as body image, functional and social skills, and emotional health). Idacio may help improve the work productivity and activity impairment in caregivers of children with Crohn’s disease.
Idacio is also used to treat inflammatory lesions (nodules and abscesses) in adults and adolescents (12 to 17 years of age, weighing ≥30 kg) with hidradenitis suppurativa.
Idacio also helps reduce the signs and symptoms of psoriasis (such as pain, itching and scaly patches on skin).
Idacio helps control uveitis by reducing the risk of inflammation and loss of vision in adult and pediatric patients.
Idacio, however, can also lower your/your child’s body’s ability to fight infections. Taking Idacio can make you/your child more prone to getting infections or make any infection you/your child have worse.
What are the ingredients in Idacio?
Medicinal ingredients: adalimumab injection
Non-medicinal ingredients: glacial acetic acid, trehalose, polysorbate 80, sodium chloride, Sodium hydroxide and Water for Injection.
Idacio comes in the following dosage forms:
- Single-use, 1 mL auto-injector containing 40 mg adalimumab injection in 0.8 mL sterile solution (50 mg/mL).
- Single-use, 1 mL prefilled glass syringe containing 40 mg adalimumab injection in 0.8 mL sterile solution (50 mg/mL).
- Single-use, 1 mL vial containing 40 mg adalimumab injection in 0.8 mL sterile solution (50 mg/mL).
All packaging components do not contain natural rubber latex.
Do not use Idacio if:
You/your child should not take Idacio if you/your child have:
- an allergy to any of the ingredients in Idacio (see What are the ingredients in Idacio? section).
- a serious infection such as tuberculosis, infections caused by bacteria or fungi, and bacterial infections that have spread throughout the body (sepsis).
- moderate to severe heart failure (NYHA class III/IV).
To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Idacio. Talk about any health conditions or problems you may have, including if you/your child:
- have or have had any kind of infection including an infection that is in only one place in your/your child’s body (such as an open cut or sore), or an infection that is in your/your child’s whole body (such as the flu). Having an infection could put you/your child at risk for serious side effects from Idacio. If you are unsure, ask your/your child’s doctor.
- have a history of infections that keep coming back or other conditions that might increase your/your child’s risk of infections, including fungal infections.
- have ever had tuberculosis, or if you/your child have been in close contact with someone who has had tuberculosis. If you/your child develop any of the symptoms of tuberculosis (a dry cough that doesn't go away, weight loss, fever, night sweats) call your/your child’s doctor right away. Your/your child’s doctor will need to examine you/your child for tuberculosis and perform a skin test.
- resided or travelled to areas where there is a greater risk for certain kinds of infections such as tuberculosis, histoplasmosis, coccidioidomycosis, blastomycosis, or parasitic infections. These infections are caused by a bacteria or a fungus that can affect the lungs or other parts of your/your child’s body. If you/your child Idacio these may become active or more severe. If you don’t know if you/your child have lived in or travelled to an area where these infections are common, ask your/your child’s doctor.
- have ever had liver injury or hepatitis B virus infection or are at risk of developing this infection. Signs and symptoms include the following: yellowing of the skin or eyes (jaundice), feeling of sickness, tiredness, loss of appetite, joint pain, fever, dark brown-colored urine, vomiting, and abdominal pain. If you/your child experience any of these signs and symptoms, contact your/your child’s doctor immediately. These symptoms may occur several months after starting therapy with Idacio.
- experience any numbness or tingling or have ever had a disease that affects your/your child’s nervous system like multiple sclerosis or Guillain-Barré syndrome.
- have or have had heart failure.
- are scheduled to have major surgery or dental procedures.
- are scheduled to be vaccinated for anything. It is recommended that pediatric patients, if possible, be brought up to date with all immunizations according to current guidelines before starting Idacio.
are taking other medicines for your/your child’s rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, psoriasis, or other
- prescribed them or has told you/your child it is acceptable that you/your child take them while you/your child are taking Idacio. It is important that you tell your/your child’s doctor about any other medicines you/your child are taking for other conditions (for example, high blood pressure medicine) before you/your child start taking Idacio.
- are taking any over-the-counter drugs, herbal medicines and vitamin and mineral supplements.
are pregnant or could become pregnant
- are breast-feeding or plan to breast-feed.
If you/your child are not sure or have any questions about any of this information, ask your/your child’s doctor.
Other warnings you should know about:
If you/your child received Idacio while pregnant, your/her baby may be at higher risk for getting an infection for up to approximately five months after the last dose of Idacio received during pregnancy. It is important that you/she tell your/her baby's doctors and other healthcare professionals about your/her Idacio use during pregnancy so they can decide when your/her baby should receive any vaccine.
Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.
The following may interact with Idacio:
You/your child should not take Idacio with:
- other TNF-blockers such as Enbrel®, Remicade®, Cimzia®, or Simponi®
- abatacept (Orencia®)
- anakinra (Kineret®)
If you/your child have questions, ask your/your child’s doctor.
How to take Idacio:
Idacio is administered by injection under the skin (by subcutaneous injection).
Usual dose:
Adults with Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis:
- The recommended dose is 40 mg administered every other week as a subcutaneous injection.
Patients, aged 2 years and older, with polyarticular juvenile idiopathic arthritis:
- weighing 10 kg to less than 30 kg: the recommended dose of Idacio is 20 mg every other week.
- weighing 30 kg or more: the recommended dose of Idacio is 40 mg every other week.
Patients who require a dose of less than 40 mg must use the vial presentation of Idacio, as the Pen cannot deliver doses less than 40 mg.
Adults with Crohn’s Disease or Ulcerative Colitis:
- The recommended dose is 160 mg at Week 0, followed by 80 mg at Week 2 administered by subcutaneous injection. The first dose of 160 mg can be given in one day (four 40mg injections) or split over two consecutive days (two 40 mg injections each day). The second dose of 80 mg at Week 2 is given as two 40 mg injections in one day.
- The recommended maintenance dose regimen is 40 mg every other week beginning at Week 4.
Adults with Hidradenitis Suppurativa:
- The recommended initial dose is 160 mg, followed by 80 mg two weeks later administered by subcutaneous injection. The first dose of 160 mg at Week 0 can be given in one day (four 40 mg injections) or split over two consecutive days (two 40 mg injections). The second dose of 80 mg at Week 2 is given as two 40 mg injections in one day.
- The recommended maintenance dose regimen is 40 mg every week beginning four weeks after the initial dose.
Adults with Psoriasis or Uveitis:
- The recommended dose is an initial dose of 80 mg, followed by 40 mg given every other week starting one week after the initial dose administered by subcutaneous injection. The first dose of 80 mg can be given as two 40 mg injections.
Children, 13 to 17 years of age weighing ≥40 kg, with Crohn’s disease:
- For children weighing ≥40 kg, the recommended dose is 160 mg initially at Week 0 (given as four 40 mg injections in one day, or as two 40 mg injections per day for two consecutive days), followed by 80 mg at Week 2 (given as two 40 mg injections). At Week 4, you/your child will begin a maintenance dose of 20 mg every other week. Depending on your/your child’s response, the doctor may increase the dose to 40 mg every other week (given as one 40 mg injection).
Patients who require a dose of less than 40 mg must use the vial presentation of Idacio, as the Pen cannot deliver doses less than 40 mg.
Adolescents, 12 to 17 years of age weighing ≥30 kg, with Hidradenitis Suppurativa:
- The recommended initial dose is 80 mg administered by subcutaneous injection, followed by 40 mg every other week starting one week later. Depending on your/your child’s response, the doctor may increase the dose to 40 mg every week.
Children, from 2 years of age with Uveitis:
- weighing less than 30 kg: the usual dose of Idacio is 20 mg every other week with methotrexate. Your child’s doctor may also prescribe an initial dose of 40 mg to be administered one week prior to the start of the usual dose if your child is older than 6 years of age.
- weighing 30 kg or more: the usual dose of Idacio is 40 mg every other week with methotrexate. Your child’s doctor may also prescribe an initial dose of 80 mg to be administered one week prior to the start of the usual dose.
Patients who require a dose of less than 40 mg must use the vial presentation of Idacio, as the Pen cannot deliver doses less than 40 mg.
Overdose:
| If you think you, or a person you are caring for, have taken too much Idacio, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms. |
|---|
Missed dose:
If you/your child forget to give yourself/your child an injection, you/your child should inject the missed dose of Idacio as soon as you/your child remember. Then administer the next dose as you/your child would have on the originally scheduled date.
What are possible side effects from using Idacio?
These are not all the possible side effects you/your child may feel when taking Idacio. If you/your child experience any side effects not listed here, contact your/your child’s healthcare professional. Please also see Warnings and Precautions.
Like all medicines, Idacio can cause side effects. Most side effects are mild to moderate. However, some may be serious and require treatment. Tell your/your child’s doctor immediately if you/your child experience any of the following:
- severe rash, hives or other signs of allergic reaction
- swollen face, hands, feet
- trouble breathing, swallowing
- sudden weight gain (this is possibly indicative of new or worsening heart failure)
- bruising or bleeding very easily, looking very pale; this could mean a blood problem such as low red blood cells (anemia) or low platelets.
Tell the doctor as soon as possible if you/your child notice any of the following:
- signs of infection such as fever, malaise, wounds, dental problems, burning on urination
- feeling weak or tired
- coughing
- tingling
- numbness
- double vision
- arm or leg weakness
- arm or leg pain, swelling or redness
- bump or open sore that does not heal
- red scaly patches or raised bumps that are filled with pus (this could be new or worsening hidradenitis suppurativa, new or worsening psoriasis or a skin infection)
- alopecia (loss of hair)
- changes in the colour of the skin
- changes in the colour of your/your child’s urine (dark or red)
- worsening of the appearance of a scar
- night sweats
- weight loss
- pain in the abdomen or chest
| Serious side effects and what to do about them | ||||||
|---|---|---|---|---|---|---|
| Symptom/effect | Talk with your healthcare professional | Stop taking drug and get immediate medical help | ||||
| Only if severe | In all cases | |||||
| VERY COMMON | ||||||
| Injection site reaction | √ | |||||
| COMMON | ||||||
| Cough and cold symptoms, including sore throat | √ | |||||
| Headache | √ | |||||
| Rash | √ | |||||
| Nausea | √ | |||||
| Pneumonia | √ | √ | ||||
| Fever | √ | |||||
| Abdominal pain | √ | |||||
| UNCOMMON | ||||||
| Tuberculosis | √ | √ | ||||
| Other serious infections | √ | √ | ||||
| Nerve disorder | √ | √ | ||||
| Appendicitis | √ | √ | ||||
| Blood clots: abdominal pain, chest pain, leg or arm pain with redness and swelling | √ | √ | ||||
| Bladder infection (painful urination) | √ | √ | ||||
| Hepatitis [jaundice (yellow skin, dark urine), abdominal pain, tiredness] | √ | √ | ||||
If you/your child have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your/your child’s daily activities, talk to your/your child’s healthcare professional.
General Advice About Prescription Medicines
Talk to your/your child’s doctor or other healthcare provider if you/your child have any questions about this medicine or your/your child’s condition. Medicines are sometimes prescribed for purposes other than those listed in a PATIENT MEDICATION INFORMATION leaflet. If you/your child have any concerns about this medicine, ask the doctor. The doctor or pharmacist can give you/your child information about this medicine that was written for health care professionals. Do not use this medicine for a condition for which it was not prescribed. Do not share this medicine with other people. A toll-free information service is also available at 1-877-821-7724.
Reporting Side Effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice. |
|---|
Storage:
Store between 2oC and 8oC (in a refrigerator) in the original carton until ready to use. DO NOT FREEZE. Protect from light. Refrigerated Idacio remains stable until the expiration date printed on the auto-injector, prefilled syringe or vial. Do not use beyond the expiration date.
When needed, for example when you/your child are travelling, an Idacio auto-injector (pen) or prefilled syringe can be stored at room temperature (up to 25oC/77oF) for a single maximum period of 28 days – be sure to protect it from light.
Once taken out of the refrigerator for room temperature storage, an Idacio auto-injector (pen) or prefilled syringe must be used within 28 days, even if it is put back in the refrigerator. If not used within 28 days, the Idacio auto-injector (pen) or prefilled syringe must be discarded. You should record the date when the Idacio auto-injector (pen) or prefilled syringe is first removed from the refrigerator. Care should be taken to avoid dropping or crushing the product as it contains a glass syringe.
If needed, the Idacio dose may be prepared ahead of time by withdrawing it from the vial and holding it in the syringe provided in the kit. The solution in the syringe may be held at room temperature for up to 3 hours.
Keep out of reach and sight of children.
If you want more information about Idacio:
- Talk to your/your child’s healthcare professional.
- Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html) the manufacturer’s website (https://www.fresenius-kabi.com/en-ca), or by calling 1-877-821-7724.
Fresenius Kabi Canada Ltd.
165 Galaxy Blvd, Suite 100,
Toronto, ON M9W 0C8
Last Revised:
Idacio is a trademark of Fresenius Kabi AG. Fresenius Kabi AG is a trademark of Fresenius SE.
Instructions for use:
PrIdacio®
Adalimumab injection
40 mg/0.8 mL (50 mg/mL)
Sterile solution for Subcutaneous (SC) use
Single use Auto-injector (prefilled pen)
For your/your child’s protection, it is important that you follow these instructions.
| Get Familiar with your Idacio Prefilled Pen |
|---|
![]() |
Step 1: Prepare for your injection Each box of Idacio prefilled pens comes with two pens.
|
Put it on a clean flat surface. | ![]() |
|---|---|
| |
Do not warm the prefilled pen any other way, such as in a microwave, hot water, or direct sunlight. Do not remove the needle cap while allowing syringe to reach room temperature. | ![]() |
Step 2: Wash your hands Wash your hands well with soap and water and dry them. Gloves will not replace the need for washing hands. | |
Step 3: Check the prefilled pen
Do not use the prefilled pen if the liquid contains particles, or is cloudy or if it is colored, or has flakes in it or shows any sign of damage. If so, throw it away in a sharps disposal container and contact your healthcare Professional or pharmacist. | |
Do not use the prefilled pen if the name on the label is not Idacio and/or the expiration date on the label has passed. If so, throw away the prefilled pen in a sharps disposal container and contact your healthcare professional or pharmacist. | ![]() |
Step 4: Choose and clean the injection site
| ![]() | ||
|---|---|---|---|
Do not inject into an area that is sore (tender), bruised, red, hard, scarred or where you have stretch marks. If you have psoriasis, do not inject into any lesions or red, thick, raised or scaly patches.
| |||
| Step 5: Give your Injection | |||
You may see drops of liquid at the needle tip.
Do not twist the cap. Do not recap the prefilled pen. | ![]() | ||
| ![]() | ||
| ![]() |
|---|---|
Do not lift the prefilled pen from the skin until the plunger has moved all the way down and all the liquid has been injected. | ![]() |
Call your healthcare professional or pharmacist if you have any problem. | ![]() |
| |
Step 6: Throw away your prefilled Pen Throw away your used prefilled Pen in a sharps disposal container right away after use. | |
Step 7: Record your Injection To help you remember when and where to do your next injection, you should keep a record of the dates and injection sites used for your injections (Fig. J). | ![]() |
Instructions for use:
PrIdacio®
Adalimumab injection
40 mg/0.8 mL (50 mg/mL)
Sterile solution for Subcutaneous Injection
Single use prefilled syringe
For your/your child’s protection, it is important that you follow these instructions.
Get Familiar with your Idacio Prefilled Syringe ![]() |
|---|
Step 1: Prepare for your injection Each box of Idacio prefilled syringe comes with two syringes
Open your sharps disposal container so it is ready to use.
|
Take a syringe out of the original box:
Put it on a clean flat surface. | ![]() | ||
|---|---|---|---|
| |||
Do not warm the syringe any other way, such as in a microwave, hot water, or direct sunlight. Do not remove the needle cap while allowing syringe to reach room temperature. | ![]() | ||
Step 2: Wash your hands Wash your hands well with soap and water and dry them. Gloves will not replace the need for washing hands | |||
Step 3: Check the Syringe
Do not use the syringe if it shows any sign of damage. If so, throw away the syringe in a sharps disposal container and contact your healthcare professional or pharmacist. | ![]() | ||
| |||
Do not use the syringe if:
If so, throw away the syringe in a sharps disposal container and contact your healthcare professional or pharmacist. | ![]() | |
|---|---|---|
Step 4: Choose, clean the injection site
| ![]() | |
| ||
Step 5: Give your Injection
You may see drops of liquid at the needle tip. Throw away the needle cap. Do not touch the needle. | ![]() | |
| ![]() | |
| ![]() | |
|---|---|---|
| ![]() | |
Do not remove the needle from the skin when the plunger reaches the end. | ![]() | |
Slowly release your thumb up. This will allow the needle to move up into the clear needle guard and cover the entire needle (Fig. M). Call your healthcare professional or pharmacist if you did not inject the full dose or the clear needle guard does not activate after injecting. Do not reuse a syringe in case of partial injection. Do not try to recap needle as it could lead to needle stick injury. | ![]() | |
| ||
Step 6: Throw away your Syringe Throw away your used syringe in a sharps disposal container right away after use | |
|---|---|
Step 7: Record your Injection To help you remember when and where to do your next injection, you should keep a record of the dates and injection sites used for your injections. | ![]() |
Instructions for use:
PrIdacio®
Adalimumab injection
40 mg/0.8 mL (50 mg/mL)
Sterile solution for Subcutaneous injection
Single use Vial
For your/your child’s protection, it is important that you follow these instructions.
Step 1: Gather supplies and check for damages
Check the expiration date on the side of the box. Do not use if the expiration date has passed. | |
|---|---|
Do not warm the kit any other way, such as in a microwave, hot water, or direct sunlight. | ![]() |
![]() Do not use if damaged. | |
| |
Open your sharps container so it is ready.
| |
|---|---|
Step 2: Wash your hands Wash your hands with soap, water and dry them well. Gloves do not replace the need for washing hands. | |
Step 3: Prepare your vial
Do not use the vial if:
| |
The liquid is clear, colorless, and free of particles. Do not use the vial if the liquid is cloudy, colored or has particles or flakes in it. | |
| ![]() |
| |
Do not touch the vial adapter | ![]() |
| ![]() | |
|---|---|---|
| ![]() | |
Step 4: Prepare Syringe ![]() | ||
| ![]() | |
| ![]() |
|---|---|
If the plunger rod is pulled completely out, throw away the syringe. Do not try to reinsert it and use a new kit. | ![]() |
If you still see air gaps or bubbles at the tip of the syringe, repeat this step until air gaps or bubbles are gone (Fig. K). Do not shake the syringe. Do not use the syringe if there is a large amount of air in the syringe. | ![]() |
Do not touch the syringe tip. Do not throw the vial away. | ![]() |
Step 5: Prepare Needle ![]() | |
|---|---|
Do not take the needle out of its packaging. Do not touch the yellow connector. | ![]() |
| ![]() |
| ![]() |
| Step 6: Prepare Injection | |
|---|---|
Choose a different injection site (at least 2.5 centimeters away from the previous injection site) each time to reduce redness, irritation or other skin problems. Do not inject into an area that is sore (tender), bruised, red, hard, scarred or where there are stretch marks. | ![]() |
| |
| ![]() |
| ![]() |
Step 7: Give Injection
Do not touch where you aim to inject. | ![]() | |
|---|---|---|
Note: With experience, you will find the angle (between 45° an 90°) that is most comfortable for you and the child. | ![]() | |
| ![]() | |
| ||
| ![]() | |
Call your healthcare professional if you did not inject the full dose. | ![]() | |
| ||
| Do not rub the injection site. |
|---|
Step 8: Record injection and dispose components
Keep your sharps disposal container out of the reach of children. Do not keep any unused medicine. Do not throw away the syringe or the vial in your household trash. If you do not have a sharps disposal container, you may use a household container that is:
Do not recycle your used sharps disposal container. |
















































